ARTICLE | Clinical News
T cell expansion technology regulatory update
December 3, 2001 8:00 AM UTC
TGEN's CellExSys Inc. majority owned subsidiary received U.S. Patent No. 6,316,257 covering in vitro production of antigen-specific T cells. The patent relates to CellExSys' Rapid Expansion Method (R...